Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Silodosin Versus Tamsulosin on Passage of Acutely Obstructing Ureteral Calculi (History of Last 4 Weeks) in Medical Expulsive Therapy

NCT05977647 is registered in ClinicalTrials.gov with Getz Pharma as lead sponsor.

NCT NCT05977647
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05977647 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Silodosin Versus Tamsulosin on Passage of Acutely Obstructing Ureteral Calculi (History of Last 4 Weeks) in Medical Expulsive Therapy
Lead sponsor
Getz Pharma
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2024
Completion date
June 30, 2025
Enrollment
240 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ureteric stone of lower third of ureter